Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on: November 29,2024

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Updated on:November 29,2024

Researchers find a clue to fighting fatal influenza

by Hudson Institute of Medical ResearchGSDMD deficiency limits the severity of IAV infection. Credit:Cell Death & Disease(2023). DOI: 10.1038/s41419-023-06258-1When influenza (or

Updated on: January 28,2024

Researchers find a clue to fighting fatal influenza

by Hudson Institute of Medical ResearchGSDMD deficiency limits the severity of IAV infection. Credit:Cell Death & Disease(2023). DOI: 10.1038/s41419-023-06258-1When influenza (or

Updated on:January 28,2024

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on: June 14,2024

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on:June 14,2024

A vaccine against chronic inflammatory diseases

by Institut National de la Sante et de la Recherche MedicaleCredit: CC0 Public DomainIn animals, a vaccine modifying the composition and function of the gut microbiota provides protection against

Updated on: April 01,2024

A vaccine against chronic inflammatory diseases

by Institut National de la Sante et de la Recherche MedicaleCredit: CC0 Public DomainIn animals, a vaccine modifying the composition and function of the gut microbiota provides protection against

Updated on:April 01,2024

One dose of smallpox vaccine found to be moderately effective in preventing mpox infection

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and

Updated on: October 01,2024

One dose of smallpox vaccine found to be moderately effective in preventing mpox infection

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and

Updated on:October 01,2024

Experts establish checklist detailing key consensus reporting items for primary care studies

by American Academy of Family PhysiciansCredit: Pixabay/CC0 Public DomainIn an effort to fill the need for primary care–focused guidelines, an international group of top researchers has developed

Updated on: April 07,2024

Experts establish checklist detailing key consensus reporting items for primary care studies

by American Academy of Family PhysiciansCredit: Pixabay/CC0 Public DomainIn an effort to fill the need for primary care–focused guidelines, an international group of top researchers has developed

Updated on:April 07,2024

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow

Updated on: January 26,2024

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow

Updated on:January 26,2024

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display

Updated on: January 26,2024

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display

Updated on:January 26,2024

WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on: November 15,2024

WHO launches plan to rein in 'alarming' dengue spread

This transmission electron microscopic (TEM) image depicts a number of round, Dengue virus particles that were revealed in this tissue specimen. Credit: CDC/ Frederick MurphyThe World Health Organizat

Updated on:November 15,2024

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on: April 22,2024

How does SARS-CoV-2 evade our immune defenses?

by John Hewitt , Medical XpressColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the NIA

Updated on:April 22,2024

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on: April 02,2024

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on:April 02,2024

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte

Updated on: April 01,2024

The antibodies of 'post-treatment HIV controllers'

by Pasteur InstituteCredit: Pixabay/CC0 Public DomainA very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection afte

Updated on:April 01,2024